Ana Radeljevic
Director/Board Member at MERRIMACK PHARMACEUTICALS, INC.
Net worth: 61 218 $ as of 2024-04-29
Profile
Ana Radeljevic is currently the Chief Executive Officer at Adventus Partners since 2016.
She is also an Independent Director at Merrimack Pharmaceuticals, Inc. since 2022 and the Chief Business Officer at ADRx, Inc. since 2021.
Previously, she worked as the Vice President-Financial Planning & Analysis at Revvity, Inc. from 2014 to 2016.
Ms. Radeljevic holds an MBA from Syracuse University and an undergraduate degree from Old Dominion University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-14 | 4,156 ( 0.03% ) | 61 218 $ | 2024-04-29 |
Ana Radeljevic active positions
Companies | Position | Start |
---|---|---|
MERRIMACK PHARMACEUTICALS, INC. | Director/Board Member | 2022-06-05 |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 2021-08-31 |
Former positions of Ana Radeljevic
Companies | Position | End |
---|---|---|
REVVITY, INC. | Corporate Officer/Principal | 2015-12-31 |
Training of Ana Radeljevic
Syracuse University | Masters Business Admin |
Old Dominion University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
REVVITY, INC. | Health Technology |
Private companies | 1 |
---|---|
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Ana Radeljevic